 |
The Drug Discovery World PodcastAuthor: Drug Discovery World (DDW)
Here at Drug Discovery World (DDW) we've been publishing articles written by leading experts in the Drug Discovery, Pharmaceutical, and BioPharmaceutical industries for over 20 years. DDW has grown as a quarterly business review of drug discovery and development, and now we've created this podcast to allow you to listen to our articles on the go. In our journal and this podcast, we cover topics surrounding: drug discovery; drug development; business; chemistry; enabling technologies; informatics; personalised medicine; screening; therapeutics, and much more. For the podcast we have selected recent, relevant and popular scientific articles, so that you can listen to all of the best content from Drug Discovery World. We hope you enjoy. Language: en Genres: Health & Fitness, Life Sciences, Medicine, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Could a new weight loss approach have longer term benefits than GLP-1s?
Thursday, 18 June, 2026
The latest episode of the DDW 'In Conversation With' series is available to listen to below. This week, Bruno Quinney speaks to Vincent Marion, Scientific Founder and President of AdipoPharma. AdipoPharma is a biotech leveraging research on insulin resistance and adipose tissue biology, developing a new treatment for metabolic diseases. Vincent discusses what makes AdipoPharma's lead asset different from GLP-1s, why findings into fat tissue dysfunction have been less explored in drug development, and how AdipoPharma is competing in an industry where GLP-1s are becoming increasingly accessible. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
